Ondansetron Tablet, Orally Disintegrating
Product Images NDC 51655-809

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 51655-809). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (51655 809 87 Master Bottle Label Approval Rev A 11 20)

This is a description for Ondansetron Orally Disintegrating Tablets. It is available in blister packs each containing 6 tablets. The dosage is Rx only and is described in the provided package insert. Storage instructions are included, with recommended temperate range and precautions for storing away from children. There are warnings for usage, including not removing tablets from the blister pack before using, and not using if the blister pack is damaged.*

FDA Label Image

Chemical Structure (Ondansetronod Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.